Abstract:
Introduction:
Organophosphorus (OP) poisoning is a significant public health concern,
particularly in agricultural communities. While the neurotoxic effects of OP
compounds through acetylcholinesterase (AChE) inhibition are well-established, their
impact on hepatic function remains incompletely characterized. This study aimed to
investigate the correlation between serum acetylcholinesterase levels and liver
enzymes in patients with OP poisoning and evaluate their temporal evolution and
prognostic significance.
Methods:
This prospective study included 100 patients with OP poisoning admitted to a
tertiary care center. Serum acetylcholinesterase levels and liver function tests (SGOT,
SGPT, ALP, total and direct bilirubin) were measured on days 1, 3, and 5 of
hospitalization. Severity was assessed using the Peradeniya Organophosphorus
Poisoning (POP) scale. Clinical outcomes including need for intubation, mortality,
and discharge status were recorded. Correlation analysis was performed to determine
the relationship between AChE levels and liver function parameters.
Results:
The study population comprised 53% males and 47% females, with 63% of
patients aged 21-40 years. On admission, 85% of patients had depressed AChE levels
(<5320 U/L), while 86% had elevated SGOT, 77% had elevated SGPT, and 86% had
elevated ALP. Strong negative correlations were observed between AChE levels and
liver enzymes (SGOT: r=-0.812, SGPT: r=-0.814, ALP: r=-0.631, total bilirubin: r=-
0.704, direct bilirubin: r=-0.667; all p<0.001). Patients with depressed AChE levels
had significantly higher liver enzyme levels compared to those with normal AChE.
Recovery patterns showed normalization of SGOT in all patients by day 5, while
SGPT remained elevated in 48% and bilirubin levels showed paradoxical worsening.
The overall mortality rate was 13%, with a trend toward better survival in patients
with normal AChE levels, though this was not statistically significant (p=0.14).
Conclusion:
This study demonstrates a strong inverse correlation between serum
acetylcholinesterase levels and liver enzymes in OP poisoning, indicating that
hepatotoxicity parallels the degree of cholinesterase inhibition. The high prevalence
of liver dysfunction and the varying temporal evolution of different parameters
highlight the importance of comprehensive liver function monitoring in OP poisoning.
These findings enhance our understanding of the multi-organ effects of OP
compounds and may inform more targeted approaches to assessment and management
of these patients.